Announcements Trials
Browse Landscape

Status

Completed 4Recruiting 3Active not recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Melanoma 2Glioma 1Glioblastoma 1

Interventions

TIC10 compound 2pembrolizumab 1efineptakin alfa 1avapritinib 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Glioma × pembrolizumab × Clear all
NCT03311542 2018-01-10

Expanded Access for Pembrolizumab (MK-3475)

Center Trials & Treatment

No longer available
CNSDermatologic

Glioblastoma, Glioma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡